ARGX
argenx SE
NASDAQ · Healthcare · Biotechnology · NL
$1,033.15
−1.93%Forward multiples
Based on analyst estimates
- P/E forward
- 124.03x
- P/E 2026E
- 35.92x
- P/E 2027E
- 26.91x
- P/E 2028E
- 21.27x
- P/S forward
- 36.11x
Trailing multiples
Trailing twelve months
- P/E TTM
- 27.65x
- PEG TTM
- —
- Price / book
- 7.68x
- Price / sales
- 8.33x
- Price / cash flow
- 76.00x
Enterprise value
- Enterprise value
- $59.5B
- EV / sales
- 7.67x
- EV / EBITDA
- 25.16x
- EV / EBIT
- 29.13x
- Market cap
- $64.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026